A deeptech firm developing multi-state fusion reactors to produce medical isotopes.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Series A Astral Systems secured a 23 million pound Series A first close to bring medical isotopes to market and scale production of its modular fusion reactors. | $29M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.